Patient Assistance Programs: Easing the Burden of Financial Toxicity During Cancer Treatment

McMullen, Lori

doi:10.1188/19.cjon.s2.36-40

Cited by 11 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although most pharmaceutical companies have financial assistance programs, there are often income guidelines, insurance requirements, governmental carve outs, and other restrictions. There are also charitable organizations, including foundations created by several pharmaceutical companies that may be able to help (McMullen, 2019).…”

Section: Financial Toxicitymentioning

confidence: 99%

Advances in Lung Cancer Treatment

Vrtis¹

2022

Home Healthcare Now

View full text Add to dashboard Cite

Advances in Lung Cancer TreatmentEffective, personalized treatment of a cancer requires very specific information about the characteristics of each tumor. The primary site is determined by examining the type of cells found on biopsy to identify the vital organ or tissue from which the cancerous cells originated. For example, a tumor in the lung may prove to be primary lung cancer, or a metastasis from another primary site such as the kidney or breast. If the cancer originated in the lung or bronchial tissue, it is classified as a primary lung cancer. If the cell type is from the kidney, it would be described as a kidney/renal cancer with metastasis to the lungs.In the United States, death rates for all cancers dropped by approximately 31% between 1991 and 2018. The factors that appear to have had the greatest impact are reductions in cigarette smoking, detection at earlier stages due to improved screening tools, and more effective treatment options (American Cancer Society [ACS], 2022).Lung cancer provides an excellent example of a type of cancer where treatment developments have resulted in extended survival. The three most common categories for lung cancer are non small cell lung cancer (NSCLC), small cell lung cancer, and carcinoid. Lung tumors are also categorized by the histological subtype (Figure 1). Adenocarcinomas, whether found in the lung, colon, breast or elsewhere, arise from a cell that produces mucous, for example, the alveoli in the lungs or mucous producing cells in the colon. Squamous cell carcinomas arise from epithelial cells in tissues and organs, for example, HOURS Continuing Education

show abstract

Section: Financial Toxicitymentioning

confidence: 99%

Advances in Lung Cancer Treatment

Vrtis¹

2022

Home Healthcare Now

View full text Add to dashboard Cite

show abstract

“…Screening for social determinants of health and material hardship could help identify patients at particularly high risk for distress and inequities 40,41 . Referral to social workers, case managers, patient navigators, and/or financial counseling services may prove helpful if patients report financial distress or come from rural or disadvantaged communities 42,43 . Providing DM services through telehealth (including the option of phone) can reduce financial and other barriers (transportation, childcare, etc) to access to needed resources.…”

Section: Individual Characteristicsmentioning

confidence: 99%

“…40,41 Referral to social workers, case managers, patient navigators, and/or financial counseling services may prove helpful if patients report financial distress or come from rural or disadvantaged communities. 42,43 Providing DM services through telehealth (including the option of phone) can reduce financial and other barriers (transportation, childcare, etc) to access to needed resources. It is also important to consider access to technology and preferences for which technology to use.…”

Section: Socioeconomically or Geographically Disadvantaged Patientsmentioning

confidence: 99%

Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work

Deshields

Gregorio

Flowers

et al. 2021

CA A Cancer J Clinicians

View full text Add to dashboard Cite

Distress management (DM) (screening and response) is an essential component of cancer care across the treatment trajectory. Effective DM has many benefits, including improving patients' quality of life; reducing distress, anxiety, and depression; contributing to medical cost offsets; and reducing emergency department visits and hospitalizations. Unfortunately, many distressed patients do not receive needed services. There are several multilevel barriers that represent key challenges to DM and affect its implementation. The Consolidated Framework for Implementation Research was used as an organizational structure to outline the barriers and facilitators to implementation of DM, including: 1) individual characteristics (individual patient characteristics with a focus on groups who may face unique barriers to distress screening and linkage to services), 2) intervention (unique aspects of DM intervention, including specific challenges in screening and psychosocial intervention, with recommendations for resolving these challenges), 3) processes for implementation of DM (modality and timing of screening, the challenge of triage for urgent needs, and incorporation of patient-reported outcomes and quality measures), 4) organization-inner setting (the context of the clinic, hospital, or health care system); and 5) organization-outer setting (including reimbursement strategies and health-care policy). Specific recommendations for evidence-based strategies and interventions for each of the domains of the Consolidated Framework for Implementation Research are also included to address barriers and challenges.

show abstract

“…Literature reviewed report financial toxicity and economics of treating cancer greatly impact on the household families living with patient with advanced (Carrera, Kantarjian et al 2018, Bouberhan, Shea et al 2019, McMullen 2019, Boby, Rajappa et al 2021. More specifically, African countries are hardly hit with resource-constrained settings.…”

Section: Introductionmentioning

confidence: 99%

Financial Toxicity Related to Advanced Cancer Patients’ Care: Case study of Selected Households of Kiambu County, Kenya

2022

JHMN

View full text Add to dashboard Cite

The aim of this study is to investigate family caregiver's experiences on household financial burden related to cancer treatment/care following referral to a palliative care unit in Kenya. Methodology: Case study approach was used to collect data from caregivers of advanced cancer patients following referral to a palliative care unit at Kijabe Mission Hospital in Kenya. This approach is best suited to gain insight into economic implication of the rising cost of cancer treatment which has put a considerable financial strain on affected families, leading to adverse outcomes of caring for patients with advanced cancer. Semi-structured in-depth interviews, documentary data and field notes, observations were used to collect information relating to financial and economic impact of the careburden experiences from theoretical sample of 12 caregivers. This approach enabled an in-depth, multifaceted explorations of complex issues related to in their real-world contexts. The case study method was particularly chosen because of its richness to gain an in-depth understanding of an issue, event, or phenomenon of interest in its natural real-life context. A sociotechnical coding matrix was used to analyze qualitative data thematically, along with additional themes that emerged from the data. All ethical considerations were observed accordingly. Findings -Four (4) male and eight (8) female caregivers interviewed were between 18 to 67 years. The study reports families facing enormous financial strain and difficulties treating their patient with advanced cancer patient. Treating patient with advanced cancer is reported to drain resources threatening to bring vicious cycle of poverty and financial stability. Family members get frustrated at their inability to meet growing demands related to care, treatment and management of their patient in advanced stage of cancer. Financial concerns, catastrophic health expenditure (CHE) and distress financing (DF as part of devastating effects of cancer, limited health insurance coverage and gaps in financing are among the key concerns identified. Unique contributions to theory, practice and policy: This study builds evidence towards social and conomic consequences of treating advanced cancer diseases that affect household families and impact on life of patients with advanced cares. Hence, seeks to shape how multidisciplinary cancer care teams' practices to become more aware of the costs of their clinical decisions. Findings of this study also form basis of review of already existing policies related to insurance coverage provided by state agency to tailor it to chronic diseases. Further research is required to mitigate financial toxicity and additional financial safety nets

show abstract

Patient Assistance Programs: Easing the Burden of Financial Toxicity During Cancer Treatment

Cited by 11 publications

References 7 publications

Advances in Lung Cancer Treatment

Advances in Lung Cancer Treatment

Addressing distress management challenges: Recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work

Financial Toxicity Related to Advanced Cancer Patients’ Care: Case study of Selected Households of Kiambu County, Kenya

Contact Info

Product

Resources

About